• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[糖尿病的干细胞治疗:进展、前景与挑战]

[Stem cell therapy for diabetes mellitus: progress, prospects and challenges].

作者信息

Urbán S Veronika, Kiss Judit, Vas Virág, Kovács János, Uher Ferenc

机构信息

Országos Gyógyintézeti Központ, Ossejt-biológia.

出版信息

Orv Hetil. 2006 Apr 30;147(17):791-7.

PMID:16780187
Abstract

Curative therapy for diabetes mellitus mainly implies replacement of missing insulin-producing pancreatic beta cells, with pancreas or islet-cell transplants. The limited supply currently available from cadaveric donor islets for transplantation, however, determines that researchers must explore alternative sources of graft material. Stem cells represent a promising solution to this problem, and current research is being aimed at the creation of islet-endocrine tissue from these undifferentiated cells. Both embryonic stem cells (derived from the inner cell mass of a blastocyst) and adult tissue stem cells (found in the postnatal organism) have been used to generate surrogate beta cells or otherwise restore beta cell functioning. Nevertheless, cell replacement therapies that are stem cell based will remain fiction rather than fact until we can efficiently and reproducibly ensure that stable, fully functional cells can be generated in vitro. It is also critical to ensure that any surrogate or regenerated beta cells have perfectly regulated insulin production, which is essential for physiological glucose homeostasis. As in every emerging field in biology, early reports seem confusing and conflicting. Therefore, discrepancies between different results need to be reconciled. In addition, encouraging studies in rodent models may ultimately set the stage for large-animal studies. In this review, the authors provide insight into research efforts to overcome existing hurdles for this promising therapy.

摘要

糖尿病的治疗性疗法主要意味着通过胰腺或胰岛细胞移植来替代缺失的产生胰岛素的胰腺β细胞。然而,目前可用于移植的尸体供体胰岛的供应有限,这决定了研究人员必须探索移植材料的替代来源。干细胞是解决这一问题的一个有前景的办法,目前的研究旨在从这些未分化细胞中创建胰岛内分泌组织。胚胎干细胞(源自囊胚的内细胞团)和成体组织干细胞(存在于出生后的生物体中)都已被用于生成替代β细胞或以其他方式恢复β细胞功能。然而,在我们能够高效且可重复地确保在体外生成稳定、功能完全的细胞之前,基于干细胞的细胞替代疗法仍将是虚构而非事实。确保任何替代或再生的β细胞具有完美调节的胰岛素分泌也至关重要,这对于生理葡萄糖稳态必不可少。如同生物学中的每个新兴领域一样,早期报告似乎令人困惑且相互矛盾。因此,需要调和不同结果之间的差异。此外,在啮齿动物模型中的鼓舞人心的研究最终可能为大型动物研究奠定基础。在这篇综述中,作者深入探讨了为克服这种有前景的疗法的现有障碍所做的研究努力。

相似文献

1
[Stem cell therapy for diabetes mellitus: progress, prospects and challenges].[糖尿病的干细胞治疗:进展、前景与挑战]
Orv Hetil. 2006 Apr 30;147(17):791-7.
2
Stem cell-based approaches to solving the problem of tissue supply for islet transplantation in type 1 diabetes.基于干细胞的方法来解决1型糖尿病胰岛移植的组织供应问题。
Int J Biochem Cell Biol. 2004 Apr;36(4):667-83. doi: 10.1016/j.biocel.2003.09.005.
3
Stem-cell therapy for diabetes mellitus.糖尿病的干细胞治疗。
Lancet. 2004;364(9429):203-5. doi: 10.1016/S0140-6736(04)16635-X.
4
Stem cells and pancreatic differentiation in vitro.干细胞与体外胰腺分化
J Biotechnol. 2004 Sep 30;113(1-3):3-13. doi: 10.1016/j.jbiotec.2004.03.023.
5
In vitro-generation of surrogate islets from adult stem cells.从成体干细胞体外生成替代胰岛。
Transpl Immunol. 2004 Apr;12(3-4):259-72. doi: 10.1016/j.trim.2003.12.011.
6
Towards stem-cell therapy in the endocrine pancreas.走向内分泌胰腺的干细胞治疗。
Trends Mol Med. 2007 Apr;13(4):164-73. doi: 10.1016/j.molmed.2007.02.002. Epub 2007 Feb 20.
7
Cell therapy for diabetes mellitus: an opportunity for stem cells?糖尿病的细胞治疗:干细胞的机遇?
Cells Tissues Organs. 2008;188(1-2):70-7. doi: 10.1159/000119407. Epub 2008 Feb 29.
8
Stem cells therapy for type 1 diabetes.1型糖尿病的干细胞疗法。
Diabetes Res Clin Pract. 2007 Oct;78(1):1-7. doi: 10.1016/j.diabres.2007.02.003. Epub 2007 Mar 8.
9
Development of cell markers for the identification and expansion of islet progenitor cells.用于鉴定和扩增胰岛祖细胞的细胞标志物的开发。
Diabetes Metab Res Rev. 2003 Sep-Oct;19(5):363-74. doi: 10.1002/dmrr.406.
10
Stem cells in the treatment of diabetes.干细胞在糖尿病治疗中的应用。
Ann Med. 2005;37(7):513-20. doi: 10.1080/07853890500300279.

引用本文的文献

1
A whole-mechanical method to establish human embryonic stem cell line HN4 from discarded embryos.一种利用全机械方法从废弃胚胎中建立人胚胎干细胞系 HN4 的方法。
Cytotechnology. 2010 Dec;62(6):509-18. doi: 10.1007/s10616-010-9311-z. Epub 2010 Oct 26.
2
Reversal of diabetes in mice by intrahepatic injection of bone-derived GFP-murine mesenchymal stem cells infected with the recombinant retrovirus-carrying human insulin gene.通过肝内注射感染携带人胰岛素基因的重组逆转录病毒的骨源绿色荧光蛋白小鼠间充质干细胞使小鼠糖尿病逆转。
World J Surg. 2007 Sep;31(9):1872-1882. doi: 10.1007/s00268-007-9168-2.